GSE206931 WDR5 inhibition WIN 1 v 6 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE206931_WDR5 inhibition_WIN_1_v_6_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE206931_WDR5 inhibition_WIN_1_v_6_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE206931_WDR5 inhibition_WIN_1_v_6_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE206931_WDR5 inhibition_WIN_1_v_6_human_up.

Results found

Linked to

 

Label

Description

 

Gene

NSUN5 pseudogene 1

Gene

MT-ATP6 pseudogene 1

Gene

PRR34 antisense RNA 1

Gene

STAG3 cohesin complex component like 5, pseudogene

Gene

lymphocyte antigen 6 family member G5B

Gene

long intergenic non-protein coding RNA 910

Gene

SDHA pseudogene 4

Gene

PDXDC2P-NPIPB14P readthrough, transcribed pseudogene

Gene

MIR124-1 host gene

Gene

peptidylprolyl isomerase E like (pseudogene)

  • Gene

    NSUN5 pseudogene 1


  • Gene

    MT-ATP6 pseudogene 1


  • Gene

    PRR34 antisense RNA 1


  • Gene

    STAG3 cohesin complex component like 5, pseudogene


  • Gene

    lymphocyte antigen 6 family member G5B


  • Gene

    long intergenic non-protein coding RNA 910


  • Gene

    SDHA pseudogene 4


  • Gene

    PDXDC2P-NPIPB14P readthrough, transcribed pseudogene



  • Gene

    peptidylprolyl isomerase E like (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.